Related Experiment Video
Updated: Jul 13, 2026
06:21
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Hypoglycemia, brain energetics, and hypoglycemic neuronal death
Sang Won Suh1,2, Aaron M Hamby1,2, Raymond A Swanson1,2
1Department of Neurology, University of California, San Francisco, California, and.
Glia
|July 31, 2007
Summary
Hypoglycemia, low blood sugar in diabetics, can impair brain function and cause neuron death. This review explores brain energy metabolism, neuronal death pathways, and astrocyte roles in hypoglycemia.
Area of Science:
- Neuroscience
- Endocrinology
- Cell Biology
Background:
- Hypoglycemia is a frequent complication for diabetic patients using glucose-lowering medications.
- Both moderate and severe hypoglycemia can lead to neurological impairment and neuronal cell death.
Purpose of the Study:
- To review the bioenergetic basis of brain dysfunction during hypoglycemia.
- To examine the mechanisms of hypoglycemia-induced neuronal death.
- To elucidate the role of astrocytes in these processes.
Main Methods:
- Literature review focusing on bioenergetics, neuronal cell death, and astrocyte metabolism in the context of hypoglycemia.
- Synthesis of recent advances in understanding hypoglycemia pathophysiology.
Main Results:
- Hypoglycemia disrupts central nervous system bioenergetics, particularly the coupling of neuronal and astrocyte metabolism.
- Specific neuronal populations exhibit vulnerability to hypoglycemia-induced death.
- Neuronal cell death involves distinct molecular pathways triggered by low glucose.
Conclusions:
- Understanding hypoglycemia's impact on brain bioenergetics and neuronal death is crucial for diabetic patient care.
- Astrocytes play a significant role in modulating neuronal responses to hypoglycemia.
- Further research into these mechanisms may reveal new therapeutic targets.
Related Concept Videos
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:18Metabolic States of the Body: The Postabsorptive State
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
01:24Metabolic States of the Body: Fasting and Starvation
During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
01:21Cytotoxic Edema: Pathophysiology
Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...